Aligos Therapeutics Inc. (ALGS)

NASDAQ: ALGS · Real-Time Price · USD

5.97

-0.07 (-1.08%)

At close: May 02, 2025, 10:24 AM

Aligos Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Net Income	-131.21M	-87.68M	-96.05M	-128.33M	-108.54M	-52.26M	-13.93M
Depreciation & Amortization	2.62M	3.07M	3.67M	3.78M	3.33M	2.3M	1.29M
Stock-Based Compensation	8.45M	12.65M	14.69M	13.46M	2.98M	752K	179K
Other Working Capital	-5.01M	-7.31M	-3.27M	-4.34M	16.19M	3.29M	1.91M
Other Non-Cash Items	44.35M	2.49M	-159K	86K	11.39M	-1.23M	1.64M
Deferred Income Tax	n/a	n/a	n/a	n/a	530K	n/a	-110K
Change in Working Capital	-4.96M	-9.53M	-1.55M	-4.65M	16.06M	3.67M	4.88M
Operating Cash Flow	-80.74M	-79M	-79.39M	-115.66M	-74.26M	-46.77M	-6.05M
Capital Expenditures	-130K	-19K	-943K	-892K	-2.06M	-2.79M	-2.52M
Cash Acquisitions	n/a	n/a	25.35M	-3.91M	-34.82M	-9.58M	n/a
Purchase of Investments	-108.15M	-11K	-104.27M	-19.09M	-45.28M	-70.42M	-66.77M
Sales Maturities Of Investments	90M	45.01M	78.92M	23M	80.1M	80M	n/a
Other Investing Acitivies	n/a	n/a	-25.35M	3.91M	34.82M	9.58M	-72.84M
Investing Cash Flow	-18.28M	44.98M	-26.29M	3.02M	32.76M	6.79M	-69.29M
Debt Repayment	-83K	-96K	-61K	-79K	-58K	-43K	5M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	438K	70.98M	225K	172K	n/a	612K	77K
Financial Cash Flow	355K	88.33M	164K	78.68M	192.35M	85.53M	99.89M
Net Cash Flow	-98.67M	54.31M	-105.52M	-33.96M	150.84M	45.56M	24.55M
Free Cash Flow	-80.87M	-79.02M	-80.33M	-116.55M	-76.33M	-49.55M	-8.56M